Insmed Incorporated (INSM)
NASDAQ·Healthcare·Biotechnology
$109.37
-2.84%
Mkt Cap $21.18B
Analyst Ratings
Buy
18
Hold
0
Sell
0
Price Target (77 analysts)
$196.93
Range $169.00 – $235.00
Implied Upside
+80.1%
Consensus $196.93 vs current $109.37
NASDAQ·Healthcare·Biotechnology
$109.37
-2.84%
Mkt Cap $21.18B
Buy
18
Hold
0
Sell
0
Price Target (77 analysts)
$196.93
Range $169.00 – $235.00
+80.1%
Consensus $196.93 vs current $109.37